Delivery Order SPE2DB24D1104-SPE2DB25FYDS2
Award Date 7/24/25
Potential Completion Date 7/25/25
Potential Value $32K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $46,661.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). This competitive award was issued on October 30, 2025, with an ultimate completion date of October 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of HIV infection, representing a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $23,421.82 on June 26, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, executed through competitive procedures. The contract is set to conclude on June 27, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an HIV treatment...
- The Defense Logistics Agency awarded a $15,696.60 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with a completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of HIV infection, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a $58,730.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 14, 2025. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of human...
- The Defense Logistics Agency awarded a delivery order valued at $7,948.35 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by July 29, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an...
- The Defense Logistics Agency awarded a $36,289.78 firm fixed price delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of July 22, 2025. This non-set-aside contract was competitively awarded on July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is a brand-name antiretroviral medication used in HIV treatment, reflecting the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $74,948.97 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV treatment,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,904.16 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in units of 30 on November 14, 2025. This non-competitive, firm fixed-price delivery order is scheduled for completion by November 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is a prescription antiretroviral medication used in the treatment of HIV, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $42,309.65 to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, which represents a non-competitive set-aside award, is scheduled for completion by October 28, 2025, with performance to take place at the contractor's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is a prescription antiretroviral...
- The Defense Logistics Agency awarded a delivery order valued at $20,483.16 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on December 4, 2025, with a completion date of December 5, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV treatment, reflecting the Defense Logistics...